Hold the drops for 45 seconds instead of the recommended two minutes and you have just swallowed most of your dose into a stomach full of digestive enzymes that will destroy the peptide before it does anything useful
SOUL: CVOT 13 Study design: A randomized, international, double-blind, parallel-group, placebo-controlled, event-driven, superiority phase 3b trial in adults with T2D and established atherosclerotic cardiovascular disease, CKD, or both
For detailed injection guidance, see the complete peptide injection guide and how to inject GLP-1 for step-by-step technique instructions
Data from clinical studies have also shown that renal impairment in patients with overweight or obesity does not impact the pharmacokinetics of tirzepatide [see Use in Specific Populations (8.6)]
Prescription Medication Cost of your medication is included